Best treatments for atrial fibrillation (AFib)

Understanding atrial fibrillation

Atrial fibrillation (AFib, AF) is an irregular — often fast — heart rhythm that starts in the heart's two upper chambers. The CDC describes it as the most common type of treated heart arrhythmia, and warns that some people who have AFib don't know they have it and have no symptoms; when symptoms do appear they are typically palpitations, extreme fatigue, lightheadedness, shortness of breath or chest pain. According to the NHLBI, blood may pool in the heart, which raises the risk of forming clots. That is why AFib is treated as a stroke condition, not just a rhythm annoyance: the CDC states that, after standard stroke risk factors were accounted for, AFib was associated with an approximately fivefold increased risk of ischemic stroke, and that it causes about 1 in 7 strokes. The CDC also attributes about 1 in 5 AFib cases to high blood pressure. MedlinePlus (NLM) says a provider will likely order heart tests such as an electrocardiogram (EKG or ECG) and an echocardiogram, and may ask you to wear a heart monitor that records your heart's electrical activity — which matters, because an episode that comes and goes can be absent on the day you sit for the ECG. The labels confuse people. The 2023 ACC/AHA/ACCP/HRS guideline defines paroxysmal AF as terminating within 7 days, persistent as continuous beyond 7 days, and long-standing persistent as continuous for more than 12 months. "Permanent" is the one most often misread: the guideline defines it as the point where patient and clinician jointly decide to stop further attempts to restore sinus rhythm — a treatment decision, not a biological verdict. The same guideline calls the old term "chronic AF" obsolete and says it should be abandoned. This is general information, not medical advice; decisions about AFib belong with your own clinician.

Frequently asked

What is the best medication for AFib?

AFib is atrial fibrillation. There isn't a single "best" medication for everyone — The 2023 ACC/AHA/ACCP/HRS atrial fibrillation guideline separates stroke prevention from rhythm/rate management. For stroke prevention, it recommends anticoagulation when the estimated annual thromboembolic risk is 2% or more per year (for example, a CHA2DS2-VASc score of 2 or more in men and 3 or more in women), and it recommends direct oral anticoagulants (DOACs) over warfarin except in people with a mechanical heart valve or moderate-to-severe rheumatic mitral stenosis. Notably, it states that aspirin — alone or with clopidogrel — is not recommended as an alternative to anticoagulation. For acute rate control in hemodynamically stable patients with a rapid ventricular response, it recommends beta blockers or nondihydropyridine calcium channel blockers (verapamil, diltiazem — the latter two only where ejection fraction is above 40%). It also raised catheter ablation to a Class 1 first-line rhythm-control option in selected patients, and recommends weight loss (ideal target at least 10%) for patients with a BMI above 27.. Compare every option ranked above by our independent recall-safety rating (not an efficacy measure); this is general information, not medical advice.

What treats atrial fibrillation?

Our catalog lists 22 products that may treat atrial fibrillation, based on NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. They're rated where FDA recall-safety data exists; the current top-rated option is propafenone hydrochloride.

What is the best-rated treatment for atrial fibrillation?

By our independent recall-safety rating — not an efficacy measure — propafenone hydrochloride ranks highest among the products we list for atrial fibrillation. Always consult a professional.

How are these treatments ranked?

By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.

What types of drugs treat atrial fibrillation?

Treatments for atrial fibrillation span FDA drug classes including antiarrhythmic, cardiac glycoside, calcium channel blocker, beta-adrenergic blocker. Compare every option side by side, ranked by independent rating, above.

Treatment associations are derived from NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. This is general reference, not medical advice — always consult a licensed professional.